4051 completed, 1855 unknown, 1405 recruiting, 759 terminated. 2631 Phase 2, 2581 Not applicable, 1617 Phase 1, 811 Phase 3, 159 Phase 4.
Follow Intestinal Neoplasms: new trials by email Literature Review of Intestinal Neoplasms trials Research Report on Intestinal Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Improving Clinic Delivery of HIV-related Anal Health Services PEACHES 2.0 Implementation Strategies - HIV, Gonorrhea | Not applicable | Not yet recruiting | Albert Einstein College of Medicine | 8 | 2028-02-01 | 2026-10-13 |
| The Impact of a Patient Decision Aid on Treatment Choices for Patients With an Unexpected Malignant Colorectal Polyp Shared Decision Making using a Patient Decision Aid. - Shared Decision Making, Colonic Polyp | Phase 2 | Not yet recruiting | Vejle Hospital | 110 | 2028-02-01 | 2026-04-30 |
| CA102N Combined With TAS-102 Compared to Bevacizumab Combined With TAS-102 in Subjects With Metastatic Colorectal Cancer CA102N, TAS-102, Bevacizumab - Metastatic Colorectal Cancer | Phase 2 | Suspended | Holy Stone Healthcare Co., Ltd | 100 | 2027-12-01 | 2026-09-18 |
| Application of Multimodal MRI in Histological Grading and Prognostic Assessment of Rectal Cancer intravoxel incoherent motion magnetic resonance imaging - Rectal Neoplasms, Prognosis | Not yet recruiting | Sichuan Cancer Hospital and Research Institute | 400 | 2027-11-01 | 2025-12-08 | |
| SGA-OCRC: Prediction of 90-Day Major Adverse Postoperative Outcomes in Octogenarians With Resectable Colorectal Cancer Octogenarian Patients With Non-metastatic Resectable Colorectal Cancer | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 1000 | 2027-06-01 | 2026-10-29 | |
| Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial Balstilimab, Biopsy Procedure, Biospecimen Collection - Colorectal Adenocarcinoma, Stage II Colorectal Cancer AJCC v8 | Phase 2 | Recruiting | National Cancer Institute (NCI) | 20 | 2027-05-25 | 2026-09-29 |
| CCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and Systemic Therapy for the Treatment of Colorectal Cancer Liver Metastases, CHAMP Trial Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver | Phase 1 | Not yet recruiting | City of Hope Medical Center | 36 | 2027-05-06 | 2026-09-25 |
| PET/MRI in Rectal Cancer Total Neo-adjuvant Therapy, 18FDG-PET/MRI scan - Rectal Cancer | Phase 2 | Not yet recruiting | AHS Cancer Control Alberta | 40 | 2027-05-01 | 2026-10-28 |
| Liver Transplantation for Non-Resectable Colorectal Liver Metastases Without Local Treatment Options Liver transplantation - Colorectal Neoplasms, Liver Neoplasms | Not applicable | Not yet recruiting | Charite University, Berlin, Germany | 260 | 2027-04-01 | 2026-09-10 |
| Cancer Awareness Among Syrian Migrants PMT-Based Cancer Screening Educational Intervention, PMT-Based Cancer Screening Education Program - Breast Cancer Screening, Cervical Cancer Screening | Not applicable | Not yet recruiting | Toros University | 30 | 2027-03-09 | 2026-10-15 |
| Life Expectancy-informed Colorectal Cancer Screening Decision Tool - Colorectal Cancer Control and Prevention | Not applicable | Not yet recruiting | Kathryn Martinez | 15000 | 2027-03-01 | 2026-10-20 |
| Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)] - Colon Cancer | Phase 2 | Not yet recruiting | John Strickler, M.D. | 24 | 2027-03-01 | 2026-11-05 |
| A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients Dietary Fiber, Enema Administration, Loperamide Hydrochloride - Low Anterior Resection Syndrome, Rectal Carcinoma | Not applicable | Recruiting | Ohio State University Comprehensive Cancer Center | 80 | 2027-02-15 | 2026-10-06 |
| OSCAR II STUDY - The ONCObind CTC Removal Study ONCObind (Onco-Seraph) 100 Filter, Matched Controls - Pancreatic Ductal Adenocarcinoma (mPDAC), Metastatic Colorectal Carcinoma (mCRC) | Not applicable | Not yet recruiting | ExThera Medical Corporation | 120 | 2027-01-15 | 2026-04-17 |
| A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP). ST316 IV - Familial Adenomatous Polyposis (FAP) | Phase 1 | Not yet recruiting | Sapience Therapeutics | 40 | 2027-01-04 | 2026-08-12 |
| Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial Bevacizumab, Biopsy Procedure, Biospecimen Collection - Metastatic Appendix Carcinoma, Metastatic Colorectal Carcinoma | Phase 3 | Recruiting | City of Hope Medical Center | 129 | 2027-01-04 | 2026-11-05 |
| Feasibility Study of Huangqi Yangyuan Formula for Capecitabine-Induced Adverse Reactions in Advanced Colorectal Cancer Capecitabine, Huangqi Yangyuan Formula (Chinese Herbal Decoction) - Advanced Colorectal Cancer, Capecitabine-Related Adverse Reaction | Not applicable | Not yet recruiting | Huanfang Fan | 35 | 2027-01-01 | 2026-11-03 |
| Real-World Study: Panitumumab N01 vs Cetuximab Plus FOLFOX in First-Line RAS Wild-Type mCRC Panitumumab N01, Cetuximab (EGFR inhibitor) - Colorectal Cancer Metastatic | Not yet recruiting | Fujian Medical University Union Hospital | 610 | 2027-01-01 | 2026-11-04 | |
| Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC) Cemiplimab - Colon and Rectal Cancer | Phase 2 | Recruiting | Columbia University | 20 | 2027-01-01 | 2026-11-04 |
| Alberta Cancer Exercise Dose in Colorectal Cancer Group Exercise Classes - Arm 1, Group Exercise Classes - Arm 2 - Cancer, Colorectal Cancer | Phase 2 | Not yet recruiting | University of Calgary | 90 | 2027-01-01 | 2026-11-06 |
Showing 20 of 9473. Sign in to see all of them.
Colorectal Neoplasms (6139) · Colonic Neoplasms (2382) · Rectal Neoplasms (2245) · Breast Neoplasms (809) · Neoplasms (658) · Pancreatic Neoplasms (649) · Stomach Neoplasms (565) · Carcinoma, Non-Small-Cell Lung (531) · Neoplasm Metastasis (495) · Lung Neoplasms (481) · Ovarian Neoplasms (412) · Prostatic Neoplasms (377) · Esophageal Neoplasms (306) · Melanoma (304) · Anus Neoplasms (296)
Neoplasms by Site (9429) · Digestive System Diseases (9428) · Intestinal Diseases (9419) · Gastrointestinal Diseases (9418) · Digestive System Neoplasms (9407) · Gastrointestinal Neoplasms (9273) · Neoplasms (8815) · Rectal Diseases (7940) · Colonic Diseases (7874) · Colorectal Neoplasms (3241) · Pathological Conditions, Signs and Symptoms (1639) · Neoplasms by Histologic Type (1256) · Pathologic Processes (1200) · Urogenital Diseases (1105)
Fluorouracil (670) · Oxaliplatin (652) · Bevacizumab (561) · Leucovorin (547) · Capecitabine (533) · Irinotecan (490) · Cetuximab (393) · Radiotherapy (191) · pembrolizumab (181) · Folfox protocol (166) · Panitumumab (137) · Drug Therapy (134) · Colonoscopy (121) · regorafenib (118) · Nivolumab (107)
National Cancer Institute (NCI) (216) · Fudan University (149) · Sun Yat-sen University (132) · M.D. Anderson Cancer Center (126) · Memorial Sloan Kettering Cancer Center (106) · Hoffmann-La Roche (87) · Sixth Affiliated Hospital, Sun Yat-sen University (69) · City of Hope Medical Center (64) · Pfizer (55) · Assistance Publique - Hôpitaux de Paris (54) · Alliance for Clinical Trials in Oncology (51) · Massachusetts General Hospital (47) · Chinese University of Hong Kong (46) · Eli Lilly and Company (45) · Amgen (42)
United States (3203) · China (1548) · France (778) · Spain (583) · Italy (565) · United Kingdom (505) · Canada (479) · Germany (439) · South Korea (386) · Netherlands (334) · Belgium (316) · Australia (269) · Denmark (268) · Sweden (211) · Taiwan (209)
Norman Wolmark, MD (21) · Ajay Goel, PhD (13)
PMID 36306483, PMID 15496622, PMID 35588252, PMID 37162250, PMID 31268130, PMID 33356421, PMID 26049686, PMID 26187751, PMID 28712102, PMID 30679026, PMID 31378656, PMID 32816630, PMID 33538338, PMID 18316791, PMID 19269519, PMID 19339720, PMID 21596621, PMID 21997132, PMID 22070868, PMID 26808342, PMID 32085892, PMID 33657038, PMID 36748942, PMID 37310167, PMID 37934000, PMID 38592721, PMID 42681563, PMID 15894098, PMID 16971718, PMID 17976611, PMID 20106720, PMID 22067400, PMID 22529255, PMID 23008301, PMID 23395398, PMID 23493136, PMID 23578724, PMID 25071111, PMID 26156652, PMID 26348120, PMID 26438146, PMID 27432417, PMID 27432930, PMID 27602924, PMID 27986363, PMID 28223062, PMID 29627309, PMID 30025745, PMID 30207593, PMID 30936547
2023 (55), 2025 (48), 2017 (36), 2016 (32), 2019 (32), P30CA033572 (32), 2009 (28), 2018 (28), 2015 (26), P30CA015083 (25), P30CA014089 (22), 2008 (20), 2014 (17), P30CA016672 (16), P30CA068485 (15)